期刊文献+

Correlation of the abnormal expression of HK-II and TNFAIP3 in diffuse large B-cell lymphoma with the malignant features of tumor cells

下载PDF
导出
摘要 Objective: To study the correlation of the abnormal expression of hexokinase-Ⅱ (HK-Ⅱ) and tumor necrosis factor alpha-induced protein 3 (TNFAIP3) in diffuse large B-cell lymphoma (DLBCL) with the malignant features of tumor cells. Methods: DLBCL patients who underwent surgical resection in our hospital between March 2016 and March 2018 were selected as the DLBCL group, and the patients who underwent surgical resection during the same period and were pathologically confirmed as reactive hyperplasia of lymph nodes were selected as the control group. The lesions were collected to measure the expression levels of HK-Ⅱ, TNFAIP3, proliferation genes and invasion genes. Results: HK-Ⅱ mRNA expression level in the lesions of the DLBCL group was significantly higher than that of the control group while TNFAIP3 mRNA expression level was significantly lower than that of the control group;HK-Ⅱ mRNA expression levels in the lesions of DLBCL group of patients with lymphoma stage ⅡI-IV and lymphoma group B were significantly higher than those of the patients with lymphoma stage I-Ⅱ and group A while TNFAIP3 mRNA expression levels were significantly lower than those of the patients with lymphoma stage I-Ⅱ and lymphoma group A;CyclinD2, PDE4B, BCL2, XIAP, CCL5, CXCR4 and MMP26 mRNA expression levels in the lesions of the DLBCL group were significantly higher than those of the control group, positively correlated with HK-Ⅱ and negatively correlated with TNFAIP3 while Caspase-3 and TIMP4 mRNA expression levels were significantly lower than those of the control group, negatively correlated with HK-Ⅱ and positively correlated with TNFAIP3. Conclusion: The high expression of HK-Ⅱ and the low expression of TNFAIP3 in DLBCL are closely related to the pathological process of tumor as well as the proliferation and invasion of tumor cells.
作者 Ying Qin
出处 《Journal of Hainan Medical University》 2018年第22期75-79,共5页 海南医学院学报(英文版)
  • 相关文献

参考文献6

二级参考文献44

  • 1钟美佐,黄进,翟晓,刘巍,李建璜,陈方平.MMP-9、MMP-2在非霍奇金淋巴瘤病理组织中的表达及意义[J].现代肿瘤医学,2006,14(2):218-220. 被引量:8
  • 2关立华,张淑兰.基质金属蛋白酶-26和金属蛋白酶组织抑制剂-4在子宫内膜癌组织中的表达[J].山西医药杂志,2007,36(2):121-125. 被引量:8
  • 3Gali Soria,Neora Yaal-Hahoshen,Elina Azenshtein,Sima Shina,Leonor Leider-Trejo,Larisa Ryvo,Efrat Cohen-Hillel,Alex Shtabsky,Marcelo Ehrlich,Tsipi Meshel,Iafa Keydar,Adit Ben-Baruch.Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: A basis for tumor-promoting interactions[J]. Cytokine . 2008 (1)
  • 4Andrew G Renehan,Margaret Tyson,Matthias Egger,Richard F Heller,Marcel Zwahlen.Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies[J]. The Lancet . 2008 (9612)
  • 5Gali Soria,Adit Ben-Baruch.The inflammatory chemokines CCL2 and CCL5 in breast cancer[J]. Cancer Letters . 2008 (2)
  • 6Naxin Sun,Guiwen Yang,Heng Zhao,Huub F. J. Savelkoul,Liguo An.Multidose Streptozotocin Induction of Diabetes in BALB/c Mice Induces a Dominant Oxidative Macrophage and a Conversion of T H 1 to T H 2 Phenotypes During Disease Progression[J]. Mediators of Inflammation . 2005 (4)
  • 7Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non‐obese diabetic mice[J]. Eur. J. Immunol. . 2004 (2)
  • 8Victor Appay,Sarah L Rowland-Jones.RANTES: a versatile and controversial chemokine[J]. Trends in Immunology . 2001 (2)
  • 9Michael H. Lehmann,Silke Schreiber,Heinz Vogelsang,Holger H. Sigusch.Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937[J]. Immunology Letters . 2001 (2)
  • 10Nakamura,K.,Yamagishi,S.,Adachi,H.Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Molecular Medicine . 2007

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部